Drug stocks mixed; Myriad tanks on outlook

Drug stocks were mixed Wednesday, while shares of Myriad Genetics Inc. tanked on news that 2009 revenue would come in below its previously issued forecast.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.